TOI
Oncology Institute Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.84
+0.22 ▲ +8.40%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$2.84
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.56 | Insider Own | 34.43% | Shs Outstand | 0.10B | Perf Week | 2.16% |
| Market Cap | 0.28B | Forward P/E | - | EPS next Y | 64.84% | Insider Trans | -0.19% | Shs Float | 0.06B | Perf Month | 8.4% |
| Enterprise Value | 0.35B | PEG | - | EPS next Q | -0.08 | Inst Own | 35.87% | Short Float | 14.08% | Perf Quarter | -18.86% |
| Income | -0.05B | P/S | 0.56 | EPS this Y | 57.87% | Inst Trans | 5.4% | Short Ratio | 5.3 | Perf Half Y | -10.41% |
| Sales | 0.50B | P/B | - | EPS next 5Y | - | ROA | -28.37% | Short Interest | 9.08M | Perf YTD | -20.22% |
| Book/sh | -0.16 | P/C | 8.36 | EPS past 3/5Y | -37.23% -17.58% | ROE | -3407.86% | 52W High | -41.8% ($4.88) | Perf Year | 336.99% |
| Cash/sh | 0.34 | P/FCF | - | Sales past 3/5Y | 25.81% 21.8% | ROIC | -62.18% | 52W Low | 350.79% ($0.63) | Perf 3Y | 281.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 16.74% | Gross Margin | 13.82% | Volatility(W/M) | 10.9% 8.75% | Perf 5Y | -71.96% |
| Dividend TTM | - | EV/Sales | 0.7 | Sales Y/Y TTM | 27.79% | Oper. Margin | -7.18% | ATR (14) | 0.26 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.35 | EPS Q/Q | 55.7% | Profit Margin | -10% | RSI (14) | 51.29 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.59 | Sales Q/Q | 41.58% | SMA20 | 4.26% ($2.72) | Beta | 0.26 | Target Price | $7 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -6.41% ($3.03) | Rel Volume | 5.7 | Prev Close | $2.62 |
| Employees | 641 | LT Debt/Eq | - | EPS/Sales Surpr. | 33.33% 1.55% | SMA200 | -14.66% ($3.33) | Avg Volume(3M) | 1.72M | Price | $2.84 |
| IPO | 2020/6/4 | Option/Short | Yes/Yes | Trades | 22274 | Volume | 9,779,509 | Change | 8.4% |
뉴스 로딩 중...